Pilot Trial of XFBD, a TCM, in Persons With COVID-19

Summary

The purpose of this study is to document the safety of taking traditional Chinese medicine (TCM) in patients with COVID-19 and to gain information to determine whether a study with TCM can be conducted. The study will test a traditional Chinese medicine that has been made into a granule formulation called Xuanfei Baidu Granules.

Timeline

Start

2021-03-01

Primary completion

2022-06-20

Completion

2022-06-20

Outcome

Outcome not reported

Stopped (Enrollment): “Futile Enrollment”

Drugs

Indications